aacr metformin brakes prostate tumor growth
Two new studies indicate that immunotherapy may benefit people with leptomeningeal carcinomatosis (LMD), zyprexa and bipolar a rare but serious
Read moreTwo new studies indicate that immunotherapy may benefit people with leptomeningeal carcinomatosis (LMD), zyprexa and bipolar a rare but serious
Read moreA new study from scientists at Emory Vaccine Center and Winship Cancer Institute of Emory University reports that the immune
Read moreResearchers at City of Hope, a world-renowned research and treatment center for cancer, diabetes and other life-threatening diseases, looked at
Read moreWake Forest researchers and clinicians are using patient-specific tumor ‘organoid’ models as a preclinical companion platform to better evaluate immunotherapy
Read moreA phase 3 clinical trial co-led by Mount Sinai researchers is the first to show that immunotherapy after surgery to
Read moreBrain metastases are the most common type of brain tumors, affecting nearly 200,000 people in the United States each year.
Read moreFirst-line tebentafusp significantly improved overall survival (OS) when compared with immunotherapy or chemotherapy in patients with metastatic uveal melanoma in
Read moreClinicians should be on the lookout for immune-related adverse reactions (irAEs) even after patients have been receiving anti–programmed cell death
Read moreAn experimental immunotherapy that contains a genetically altered version of herpes simplex virus type 1 (HSV-1) was associated with a
Read moreSets of genes associated with resistance to immunotherapy in patients with metastatic urothelial cancer of the bladder have been identified
Read more